Feed HWKN
HW

Hawkins HWKN NASDAQ · Basic materials · United States

$151.09 -1.38% -$2.11

Summary

71 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 11% a year over the last 3 years.
  • Out of every 100 USD of revenue, 7.5 USD is left as net profit.
  • It earns 9.9 USD a year on every 100 USD of invested capital.

What to watch

  • The share price is above the Bulios Fair Price.
  • It missed profit estimates 5 times in the last 8 quarters.
  • Revenue growth is slowing: 5.0% a year over the last 3 years against 13% over 5 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Overvalued Price today $151.09

By our assumptions the business is worth less than its shares cost today.

P/E today 36.6 52% higher
5-year average P/E 24.1
P/E today 36.6
Chemicals - Specialty industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 36.6 USD for 1 USD of yearly profit. Over the last five years it was 24.1 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 5.0% a year. Earnings per share grew by 11% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Chemicals - Specialty) 6.0 USD

Out of every 100 USD of revenue, 7.5 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 2.7 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.52%
Paid out of profit
19%
Raised in a row
3 years

You receive $0.78 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $157 is 3.9% above today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2026

By product

By region

The company reports no revenue by region.

Nutrition brings in 32% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy